Increasing Incidence, New Treatment Guidelines & Increased R&D to Drive the Global Sepsis Therapeutics Market
The global market for Sepsis Therapeutics is projected to reach US$293.2 million by 2024 , driven by growing aging population, increasing disease incidence, and new treatment protocols. Increased R&D efforts are also expected to drive the global market. Sepsis has become a focal area in the medical community. It is currently regarded a medical emergency, on par with stroke and myocardial infarction. The global market for sepsis therapeutics is driven by increasing incidence of sepsis and growing geriatric population. Further, the increasing number of surgeries and hospital-acquired infections, and increasing research and clinical trials in this area support growth of the market. Current treatment options for treating sepsis are mostly confined to antimicrobials, including anti-bacterials, anti-fungals, anti-virals; and vasopressors, such as Norepinephrine, epinephrine, phenylephrine, vasopressin, and dopamine; and adjunctive therapy. Further, the market grow...